These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31057016)

  • 1. Applications of multiple reaction monitoring targeted proteomics assays in human plasma.
    Kontostathi G; Makridakis M; Zoidakis J; Vlahou A
    Expert Rev Mol Diagn; 2019 Jun; 19(6):499-515. PubMed ID: 31057016
    [No Abstract]   [Full Text] [Related]  

  • 2. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
    Mermelekas G; Vlahou A; Zoidakis J
    Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of Multiple Reaction Monitoring (MRM) Assays for Clinical Applications.
    Kontostathi G; Makridakis M; Bitsika V; Tsolakos N; Vlahou A; Zoidakis J
    Methods Mol Biol; 2019; 1959():205-223. PubMed ID: 30852825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Phosphoproteome Analysis Using Selected/Multiple Reaction Monitoring (SRM/MRM).
    Adachi J; Narumi R; Tomonaga T
    Methods Mol Biol; 2016; 1394():87-100. PubMed ID: 26700043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a reliable multiple reaction monitoring-based method for the quantification of obesity-associated comorbidities in serum and adipose tissue requires intensive clinical validation.
    Oberbach A; Schlichting N; Neuhaus J; Kullnick Y; Lehmann S; Heinrich M; Dietrich A; Mohr FW; von Bergen M; Baumann S
    J Proteome Res; 2014 Dec; 13(12):5784-800. PubMed ID: 25318410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques.
    Meyer JG; Schilling B
    Expert Rev Proteomics; 2017 May; 14(5):419-429. PubMed ID: 28436239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic design of MRM assays for peptide quantification.
    James A; Jorgensen C
    Methods Mol Biol; 2010; 658():167-85. PubMed ID: 20839104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-translational quantitation by SRM/MRM: applications in cardiology.
    Gianazza E; Banfi C
    Expert Rev Proteomics; 2018 Jun; 15(6):477-502. PubMed ID: 29865883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.
    Cohen Freue GV; Meredith A; Smith D; Bergman A; Sasaki M; Lam KK; Hollander Z; Opushneva N; Takhar M; Lin D; Wilson-McManus J; Balshaw R; Keown PA; Borchers CH; McManus B; Ng RT; McMaster WR;
    PLoS Comput Biol; 2013 Apr; 9(4):e1002963. PubMed ID: 23592955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics.
    Dittrich J; Ceglarek U
    Methods Mol Biol; 2017; 1619():417-430. PubMed ID: 28674901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute Quantitative Targeted Proteomics Assays for Plasma Proteins.
    Mohammed Y; Goodlett D; Borchers CH
    Methods Mol Biol; 2023; 2628():439-473. PubMed ID: 36781801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies.
    Kononikhin AS; Brzhozovskiy AG; Bugrova AE; Chebotareva NV; Zakharova NV; Semenov S; Vinogradov A; Indeykina MI; Moiseev S; Larina IM; Nikolaev EN
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of SRM, MRM(3) , and DIA for the targeted analysis of phosphorylation dynamics in non-small cell lung cancer.
    Schmidlin T; Garrigues L; Lane CS; Mulder TC; van Doorn S; Post H; de Graaf EL; Lemeer S; Heck AJ; Altelaar AF
    Proteomics; 2016 Aug; 16(15-16):2193-205. PubMed ID: 27219855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
    Percy AJ; Chambers AG; Yang J; Borchers CH
    Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Biomarker Identification and Quantification by Microparticle Proteomics.
    Harel M; Geiger T
    Methods Mol Biol; 2017; 1619():477-486. PubMed ID: 28674905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.